Abstract:

This research paper presents a comprehensive investigation into the prescribing trends for patients with co-morbid Diabetes Mellitus (DM) and Hypertension (HTN). The study aims to elucidate current practices and evaluate the efficacy of innovative treatment protocols through a controlled experimental approach. By combining established pharmaceutical interventions with emerging therapies, this research provides insights into optimizing the management of these prevalent co-morbid conditions

Description:

Co-Morbid, Diabetes, Mellitus, Healthcare, DM and HTN